Biotek-snakken — November 2021
-
Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch? https://www.proinvestor.com/investornyt/741661/could-roche-put-a-crinkle-in-biogens-alzheimers-drug-launch
-
3 Best Biopharma Stocks to Buy During
This Industrywide Fire Sale https://www.proinvestor.com/investornyt/741676/3-best-biopharma-stocks-to-buy-during-this-industrywide-fire-sale -
Biotech Stocks Facing FDA Decision In
December 2021https://www.proinvestor.com/investornyt/741752/biotech-stocks-facing-fda-decision-in-december-2021 -
Biotekfond skyder millionbeløb i IO Biotech trods horribel start på børsen i USA
Biotekfonden Advice Capital Breakthrough Biotech har lagt et millionbeløb i biotekselskabet IO Biotech, som efter få uger på børsen i USA har fået barberet næsten halvdelen af sin markedsværdi. ”Det undrer os, at den kan falde så hurtigt,” lyder det fra fondens medstifter.
(medwatch.dk)
-
Tænker Sutro godt kan matche Mirvetuximab på ORR og DOR, mens deres bivirkningsprofil er ret forskellige, så svært for mig at sige hvilken der er bedst. Sutro går jo efter en lidt laverede dosering i deres expansion studie, så lad os håbe det slår igennem på bivirkningsprofilen.
-
Nåede ikke at høre hele webcast, sagde de hvornår man forventede expansion
data?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind